| Nicole Galgoul Bitencourt, MD | |
|
11175 Campus Street, Coleman Pavilion Pediatric Rheumatology, Loma Linda, CA 92354 | |
| (909) 558-4773 | |
| (909) 558-0479 |
| Full Name | Nicole Galgoul Bitencourt |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 11175 Campus Street, Loma Linda, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386878700 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Galgoul Bitencourt, MD 11175 Campus Street, Coleman Pavilion, Loma Linda, CA 92354 Ph: (909) 558-4773 | Nicole Galgoul Bitencourt, MD 11175 Campus Street, Coleman Pavilion Pediatric Rheumatology, Loma Linda, CA 92354 Ph: (909) 558-4773 |
News Archive
Performed an average of a decade after initial facelift surgery, a "secondary" facelift can achieve similarly lasting results with a low complication rate, according to a paper in the March issue of Plastic and Reconstructive Surgery-, the official medical journal of the American Society of Plastic Surgeons (ASPS).
Small Bone Innovations, Inc. (SBi), a leading, privately held orthopedics company focused primarily on arthroplasty and trauma reconstruction technology and treatments for the small bones & joints, reported continuing growth for its S.T.A.R. ankle arthroplasty implant system with August being the biggest month ever for the S.T.A.R. in terms of revenues and surgeries.
Although teens did comment on physical benefits of exercise like flexibility and endurance, they also perceived elements like leadership and team skills development, positive emotional impact, and character development to be just as beneficial.
Merck, known outside the United States and Canada as MSD, today announced that the HPS2-THRIVE (Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events) study of TREDAPTIVE(extended-release niacin/laropiprant) did not meet its primary endpoint.
Parkinson's disease is currently the second most widespread neurogenerative pathology. Current therapies are mainly of a replacement type and pose problems in the long term, so the challenge is to establish an early diagnosis and develop neuroprotective and neurorestorative therapies that will allow the symptoms of the disease to be slowed down or even reversed.
› Verified 5 days ago
Petru Papacostea, Rheumatology Medicare: Medicare Enrolled Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Moosa Azadian, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 909-558-4085 | |
Douglas Wang, Rheumatology Medicare: Medicare Enrolled Practice Location: 11234 Anderson Street, Gme Office Westerly Suite C, Loma Linda, CA 92354 Phone: 909-558-4174 | |
Dr. Lynnetta E Skoretz, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 11201 Benton Street, #111h, Loma Linda, CA 92357 Phone: 909-825-7084 Fax: 909-777-3280 | |
Shahab Sean Shahangian, DO Rheumatology Medicare: Medicare Enrolled Practice Location: 11234 Anderson St, Loma Linda, CA 92354 Phone: 818-532-8211 | |
Mst Nurjahan Khatun, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 11234 Anderson St # C, Loma Linda, CA 92354 Phone: 408-355-8650 | |
Snorri Olafsson, M.D. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 11370 Anderson St, Ste 3150, Loma Linda, CA 92354 Phone: 909-558-2191 |